56281-36-8 Usage
Originator
Tasmaderm,Roche,Switz.,1981
Manufacturing Process
228 g of 5-(4-methoxy-2,3,6-trimethyl-phenyl)-3-methyl-penta-2,4-diene-1-
triphenylphosphonium bromide are introduced under nitrogen gassing into 910
ml of dimethylformamide and treated with cooling at 5°C to 10°C within 20
minutes with 17.5 g of a suspension of sodium hydride (about 50% by
weight) in mineral oil. The mixture is stirred for 1 hour at about 10°C, then
treated at 5°C to 8°C dropwise with 61.8 g of 3-formylcrotonic acid butyl
ester, heated for 2 hours at 65°C, subsequently introduced into 8 liters of icewater and, after the addition of 300 g of sodium chloride, thoroughly
extracted with a total of 18 liters of hexane. The extract is washed 5 times
with 1 liter of methanol/water (6:4 parts by volume) each time and 2 times
with 1.5 liters of water each time, dried over sodium sulfate and evaporated
under reduced pressure to leave 9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-
dimethyl-nona-2,4,6,8-tetraen-1-oic acid butyl ester, MP 80°C to 81°C as the
residue.125.8 g of 9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-
tetraen-1-oic acid butyl ester are introduced into 2,000 ml of absolute ethanol
and treated with a solution of 125.8 g of potassium hydroxide in 195 ml of
water. The mixture is heated to boiling under nitrogen gassing for 30 minutes,
then cooled, introduced into 10 liters of ice-water and, after the addition of
about 240 ml of concentrated hydrochloric acid (pH 2-4), thoroughly extracted
with a total of 9 liters of methylene chloride. The extract is washed with about
6 liters of water to neutrality, dried over calcium chloride and evaporated
under reduced pressure. The residue is taken up in 700 ml of hexane. The
precipitated 9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-
tetraen-1-oic acid melts at 228°C to 230°C.28.6 g of 9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-
tetraen-1-oic acid are introduced into 300 ml of benzene and treated under
nitrogen gassing with 12 g of phosphorus trichloride. The benzene is
subsequently distilled off under reduced pressure. The remaining 9-(4-
methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraen-1-oic acid
chloride is dissolved in 1,200 ml of diethyl ether. The solution is added
dropwise at -33°C into 500 ml of ethylamine and stirred for 3 hours. The
reaction mixture is then diluted with 500 ml of diethyl ether and stirred
without cooling for a further 12 hours, the ammonia evaporating. The residue
is dissolved in 10 liters of methylene chloride. The solution is washed 2 times
with 3 liters of water, dried over sodium sulfate and evaporated under reduced
pressure. The remaining N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-
dimethylnona-2,4,6,8-tetraen-1-oic acid amide melts, after recrystallization
from ethanol, at 179°C to 180°C.
Brand name
Tasmaderm (Hoffmann-LaRoche).
Therapeutic Function
Antipsoriatic
Check Digit Verification of cas no
The CAS Registry Mumber 56281-36-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,2,8 and 1 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 56281-36:
(7*5)+(6*6)+(5*2)+(4*8)+(3*1)+(2*3)+(1*6)=128
128 % 10 = 8
So 56281-36-8 is a valid CAS Registry Number.
InChI:InChI=1/C23H31NO2/c1-8-24-23(25)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(26-7)20(6)19(21)5/h9-15H,8H2,1-7H3,(H,24,25)/b11-9+,13-12+,16-10+,17-14+
